StockNews.com Begins Coverage on OncoCyte (NASDAQ:OCX)
StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a research note released on Friday morning. The brokerage issued a sell rating on the stock. Separately, Needham & Company LLC reissued a “buy” rating and set a $4.25 price objective on shares of OncoCyte in a research report on Wednesday, November 13th. […]
21 Dec 12:44 · The Markets Daily